Ashkan Shoamanesh Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2022

Use of Lipid-Lowering Drugs After Intracerebral Hemorrhage.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashkan Shoamanesh Research Topics

Disease

39	Stroke (Strokes) 05/2024 - 02/2015
34	Ischemic Stroke 05/2024 - 07/2013
27	Cerebral Hemorrhage 05/2024 - 07/2013
17	Hemorrhage 05/2024 - 06/2018
15	Embolic Stroke 01/2024 - 09/2016
11	Atrial Fibrillation 05/2024 - 01/2017
7	Thrombosis (Thrombus) 11/2023 - 01/2018
7	Embolism (Embolus) 01/2022 - 09/2016
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2024 - 01/2021
4	Headache (Headaches) 01/2023 - 01/2017
4	Siderosis 01/2023 - 03/2015
4	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2023 - 03/2015
4	Lacunar Stroke 01/2023 - 04/2015
4	Inflammation (Inflammations) 01/2023 - 02/2015
3	Hematoma 05/2024 - 01/2020
3	Infarction (Infarctions) 01/2024 - 08/2019
3	Brain Infarction 01/2024 - 09/2016
3	Cerebral Small Vessel Diseases 11/2023 - 02/2015
3	Myocardial Infarction 09/2022 - 04/2015
2	Cognitive Dysfunction 04/2024 - 01/2023
2	Transient Ischemic Attack 01/2024 - 08/2019
2	Peripheral Arterial Disease 01/2024 - 10/2021
2	Hypertension (High Blood Pressure) 12/2023 - 01/2018
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2018
2	Hemorrhagic Stroke 01/2022 - 01/2021
2	Brain Injuries (Brain Injury) 01/2022 - 01/2017
2	COVID-19 01/2021 - 01/2021
2	Atherosclerosis 01/2019 - 01/2017
1	Neurologic Manifestations (Neurological Manifestations) 05/2024
1	Rare Diseases (Rare Disease) 05/2024
1	Traumatic Cerebral Hemorrhage 01/2024
1	Edema (Dropsy) 12/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Hyperglycemia 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Pain (Aches) 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Left Ventricular Dysfunction 12/2021
1	Vascular Remodeling 10/2021
1	Venous Thromboembolism 01/2021
1	Critical Illness (Critically Ill) 01/2020
1	Atherosclerotic Plaque (Atheroma) 01/2020
1	Subdural Hematoma (Subdural Hemorrhage) 01/2020

Drug/Important Bio-Agent (IBA)

14	AnticoagulantsIBA 04/2024 - 01/2018
13	RivaroxabanIBA 01/2023 - 09/2016
13	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2022 - 04/2015
8	Factor Xa InhibitorsIBA 05/2024 - 09/2016
8	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024 - 01/2017
7	Antihypertensive Agents (Antihypertensives)IBA 12/2023 - 01/2018
7	Factor Xa (Coagulation Factor Xa)IBA 01/2022 - 09/2016
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2015
5	Factor XIa (Coagulation Factor XIa)IBA 05/2024 - 01/2022
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024 - 01/2021
4	PRT064445IBA 05/2024 - 01/2023
4	Apolipoproteins E (ApoE)IBA 10/2021 - 03/2015
3	Hemostatics (Antihemorrhagics)IBA 05/2024 - 01/2023
3	Tenecteplase FDA Link 01/2024 - 01/2021
3	LipidsIBA 01/2022 - 10/2021
3	Cilostazol (Pletal)FDA LinkGeneric 10/2021 - 04/2015
2	Deferoxamine (Desferal)FDA LinkGeneric 04/2024 - 11/2020
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 04/2024 - 01/2019
2	apixabanIBA 02/2024 - 01/2023
2	Warfarin (Coumadin)FDA LinkGeneric 01/2023 - 07/2017
2	Clopidogrel (Plavix)FDA Link 10/2021 - 08/2017
2	Vitamin K FDA Link 01/2021 - 02/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 02/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 04/2015
2	Type II Tumor Necrosis Factor ReceptorsIBA 09/2016 - 02/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2016 - 02/2015
1	eculizumab FDA Link 05/2024
1	N(4)-oleylcytosine arabinosideIBA 01/2024
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023
1	Blood Glucose (Blood Sugar)IBA 12/2023
1	GadoliniumIBA 01/2023
1	Genetic Markers (Genetic Marker)IBA 01/2023
1	AntidotesIBA 01/2023
1	edoxabanIBA 01/2023
1	CI 22IBA 01/2023
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	Collagenases (Collagenase)FDA Link 01/2022
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022
1	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 10/2021
1	AntioxidantsIBA 01/2021
1	trans-crotonin (CTN)IBA 01/2020
1	Nicardipine (Dagan)FDA LinkGeneric 01/2020
1	Troponin T (Troponin T1)IBA 01/2020
1	AngiotensinsIBA 01/2020

Therapy/Procedure

26	Therapeutics 05/2024 - 04/2015
11	Secondary Prevention 04/2024 - 04/2015
9	Thrombectomy 01/2024 - 01/2019
2	Minimally Invasive Surgical Procedures 01/2022 - 11/2020
2	Analgesia 01/2018 - 01/2017
2	Punctures 01/2018 - 01/2017
2	Thrombolytic Therapy 10/2016 - 07/2013
1	Continuity of Patient Care 01/2021
1	Time-to-Treatment 01/2021